BOBBI SCHWABE: Open Payments
NPI 1962445932 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 10 payments from 7 companies in 2025. Trend: 2023 $908 · 2024 $435 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $252 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Exact Sciences Corporation | 1 | $114 |
| BridgeBio Pharma, Inc. | 1 | $110 |
| SCPHARMACEUTICALS INC. | 1 | $100 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Novo Nordisk Inc | 1 | $15 |
Products named: REZDIFFRA, AMVUTTRA, The Cologuard Plus Collection Kit, Attruby, FUROSCIX, PIFELTRO.
Industry payments across IN — which companies pay providers there.
